The synthesis of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex multi-step organic process. Initial routes focused on peptide fragment coupling, utilizing solid-phase creation methodologies to build the long amino acid sequence. Subsequent study has explored different approaches, including enzymatic … Read More